Differences in the nitric oxide/soluble guanylyl cyclase signalling pathway in the myocardium of neonatal and adult rats

European Journal of Pharmacology

Volumn 406, Issue 2, 2000, Pages 247-255

  Vulcu, Sebastian D ^a   Wegener, Jörg W ^a   Nawrath, Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Ca2+ channel; Contractile function; L type; Myoglobin; Nitric oxide (NO); Rat; Ventricular cardiomyocyte

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE;

ADOLESCENT; AGE; ANIMAL TISSUE; ARTICLE; CALCIUM CHANNEL; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HEART MUSCLE CONTRACTILITY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMAL; ANIMALS, NEWBORN; CALCIUM CHANNELS, L-TYPE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOGLOBIN; NITRIC OXIDE; PENICILLAMINE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0034644841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00654-3     Document Type: Article

References (45)

1. + currents in frog cardiac myocytes. Br. J. Pharmacol. 121:1997;1369-1377.
2. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U. S. A. 90:1993;347-351.
3. 1G calcium channels are modulated by thiol-modifying reagents. Biophys. J. 76:1999;A408.
4. Bloch K.D., Filippov G., Sanchez L.S., Nakane M., de-la-Monte S.M. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am. J. Physiol. 272:1997;L400-L406.
5. 2+-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
6. Brady A.J., Poole-Wilson P.A., Harding S.E., Warren J.B. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263:1992;H1963-H1966.
7. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol. 108:1996;277-293.
8. Doeller J.E., Wittenberg B.A. Myoglobin function and energy metabolism of isolated cardiac myocytes: effect of sodium nitrite. Am. J. Physiol. 261:1991;H53-H62.
9. Fasold H., Riedl G., Jaisle F. Evidence for an absence of myoglobin from human smooth muscle. Eur. J. Biochem. 15:1970;122-126.
10. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
11. Flesch M., Kilter H., Cremers B., Lenz O., Sudkamp M., Kuhn-Regnier F., Bohm M. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J. Pharmacol. Exp. Ther. 281:1997;1340-1349.
12. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53:1998;123-127.
13. Garthwaite J. Neural nitric oxide signalling. Trends Neurosci. 18:1995;51-52.
14. Garthwaite J., Southam E., Boulton C.L., Nielson E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
15. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high resolution current recording from cells and cell free membrane patches. Pfluegers Arch. 391:1981;85-100.
16. Hare J.M., Colucci W.S. Role of nitric oxide in the regulation of myocardial function. Prog. Cardiovasc. Dis. 38:1995;155-166.
17. 2+ current in single heart cells. Nature. 323:1986;273-275.
18. Henry P.J., Drummer O.H., Horowitz D.J. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br. J. Pharmacol. 98:1989;757-766.
19. Ishibashi T., Hamaguchi M., Kato K., Kawada T., Ohta H., Sasage H., Imai S. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;553-561.
20. 2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J. 13:1999;313-324.
21. Jurgens K.D., Peters T., Gros G. Diffusivity of myoglobin in intact skeletal muscle cells. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3829-3833.
22. Kumar R., Joyner R.W., Hartzell H.C., Ellingsen D., Rishi F., Eaton D.C., Lu C., Akita T. Postnatal changes in the G-proteins, cyclic nucleotides and adenylyl cyclase activity in rabbit heart cells. J. Mol. Cell. Cardiol. 26:1994;1537-1550.
23. Kumar R., Namiki T., Joyner R.W. Effects of cGMP on L-type calcium current of adult and neonatal rabbit ventricular cells. Cardiovasc. Res. 33:1997;573-582.
24. Levi R.C., Alloatti G., Fischmeister R. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pfluegers Arch. 413:1989;685-687.
25. Martin W., Villani G.M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:1985;708-716.
26. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 268:1993;26286-26295.
27. Mittal C.K., Arnold W.P., Murad F. Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J. Biol. Chem. 253:1978;1266-1271.
28. Mohan P., Brutsaert D.L., Paulus W.J., Sys S.U. Myocardial contractile response to nitric oxide and cGMP. Circulation. 93:1996;1223-1229.
29. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
30. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv. Pharmacol. 26:1994;19-33.
31. Nawrath H., Bäumner D., Rupp J., Oelert H. The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br. J. Pharmacol. 116:1995;3061-3067.
32. O'Brien P.J., Shen H., McCutcheon L.J., O'Grady M., Byrne P.J., Ferguson H.W., Mirsalimi M.S., Julian R.J., Sargeant J.M., Tremblay R.R., Blackwell T.E. Rapid, simple and sensitive microassay for skeletal and cardiac muscle myoglobin and hemoglobin: use in various animals indicates functional role of myohemoproteins. Mol. Cell. Biochem. 112:1992;45-52.
33. Rakusan K., Radl J., Poupa O. The distribution and content of myoglobin in the heart of the rat during postnatal development. Physiol. Bohemoslov. 14:1965;317-319.
34. Ruetten H., Zabel U., Linz W., Schmidt H.H.H.W. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85:1999;534-541.
35. Smith J.A., Shah A.M., Lewis M.J. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol. (Lond.). 439:1991;1-14.
36. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
37. Thoenes M., Förstermann U., Tracey W.R., Bleese N.M., Nussler A.K., Scholz H., Stein B. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J. Mol. Cell. Cardiol. 28:1996;165-169.
38. Ungureanu-Longrois D., Balligand J.L., Kelly R.A., Smith T.W. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J. Mol. Cell. Cardiol. 27:1995;155-167.
39. Vulcu S.D., Wegener J.W., Nawrath H. Functional differences in the NO-sGC/cGMP pathway in cardiomyocytes from neonatal and adult rats. Biophys. J. 78:2000;1312.
40. Wegener J.W., Nawrath H. Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;322-330.
41. Wegener J.W., Gath I., Förstermann U., Nawrath H. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br. J. Pharmacol. 122:1997;1523-1529.
42. Wegener J.W., Closs E.I., Förstermann U., Nawrath H. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes. Br. J. Pharmacol. 127:1999;693-700.
43. Weyrich A.S., Ma X.L., Buerke M., Murohara T., Armstead V.E., Lefer A.M., Nicolas J.M., Thomas A.P., Lefer D.J., Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ. Res. 75:1994;692-700.
44. Wheeler M.A., Pontari M., Dokita S., Nishimoto T., Cho Y.H., Hong K.W., Weiss R.M. Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle. Mol. Cell. Biochem. 169:1997;115-124.
45. Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.M. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116:1995;1973-1978.